We confirmed that one of the most prominent biological characteristics was the significant change in FGFR3, including mutations and overexpression, and a significant increase in FGFR3 gene mutations in cluster A. Previous studies have confirmed that FGFR oncogenic mutations occur in a fifth of bladder cancers (46, 47). The gene discussed is FGFR3; the disease is urinary bladder carcinoma.